title: What should be the routine follow-up after definitive therapy of localized lung cancer?
authors.affiliation: Division of Neoplastic Diseases, Jefferson Medical College, Philadelphi, PA 19107. DFriedland@lac.jci.tju.edu.
authors.forename: R S
authors.initials: RS
authors.lastname: Pieters
authors.forename: A N
authors.initials: AN
authors.lastname: Krutchik
authors.forename: G C
authors.initials: GC
authors.lastname: Kane
authors.forename: D M
authors.initials: DM
authors.lastname: Friedland
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D002985:Clinical Protocols / Q000592:standards; D003363:Cost Control; D003952:Diagnostic Imaging / Q000191:economics; D005500:Follow-Up Studies; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D008297:Male; D008329:Managed Care Programs / Q000191:economics; D008403:Mass Screening / Q000191:economics* / Q000379:methods / Q000592:standards*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009367:Neoplasm Staging; D011379:Prognosis; D011859:Radiography; D012051:Reimbursement Mechanisms; D012052:Reimbursement, Incentive; D015996:Survival Rate